Vest Financial LLC Buys 108,480 Shares of Kenvue Inc. $KVUE

Vest Financial LLC lifted its position in Kenvue Inc. (NYSE:KVUE) by 4.7% in the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,436,986 shares of the company’s stock after purchasing an additional 108,480 shares during the period. Vest Financial LLC’s holdings in Kenvue were worth $39,552,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. Renaissance Capital LLC increased its holdings in Kenvue by 8.3% during the 2nd quarter. Renaissance Capital LLC now owns 629,177 shares of the company’s stock worth $13,169,000 after purchasing an additional 48,267 shares during the period. Farther Finance Advisors LLC grew its holdings in shares of Kenvue by 80.7% during the second quarter. Farther Finance Advisors LLC now owns 36,196 shares of the company’s stock worth $758,000 after buying an additional 16,164 shares during the last quarter. Cornell Pochily Investment Advisors Inc. raised its position in Kenvue by 144.6% during the 2nd quarter. Cornell Pochily Investment Advisors Inc. now owns 33,173 shares of the company’s stock worth $694,000 after buying an additional 19,609 shares during the last quarter. TrueMark Investments LLC grew its stake in shares of Kenvue by 8.8% during the 2nd quarter. TrueMark Investments LLC now owns 229,648 shares of the company’s stock worth $4,807,000 after purchasing an additional 18,623 shares during the period. Finally, Vanguard Group Inc. grew its position in Kenvue by 1.8% during the second quarter. Vanguard Group Inc. now owns 233,246,267 shares of the company’s stock worth $4,881,844,000 after buying an additional 4,101,880 shares during the period. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on KVUE shares. Deutsche Bank Aktiengesellschaft set a $18.00 price target on Kenvue in a research report on Friday, October 24th. Zacks Research upgraded shares of Kenvue from a “strong sell” rating to a “hold” rating in a report on Wednesday, November 26th. Canaccord Genuity Group reissued a “hold” rating and issued a $15.00 target price (down from $26.00) on shares of Kenvue in a research report on Wednesday, October 29th. Rothschild & Co Redburn raised shares of Kenvue from a “neutral” rating to a “buy” rating and dropped their price target for the stock from $22.50 to $22.00 in a research report on Friday, September 26th. Finally, Edward Jones lowered shares of Kenvue from a “strong-buy” rating to a “hold” rating in a report on Monday, November 3rd. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and twelve have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Kenvue presently has an average rating of “Hold” and a consensus target price of $20.23.

Insider Buying and Selling at Kenvue

In related news, Director Jeffrey C. Smith acquired 3,200,000 shares of the stock in a transaction dated Friday, December 12th. The stock was bought at an average cost of $17.37 per share, with a total value of $55,584,000.00. Following the purchase, the director directly owned 27,307,632 shares of the company’s stock, valued at approximately $474,333,567.84. This represents a 13.27% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.17% of the stock is currently owned by company insiders.

Kenvue Price Performance

Kenvue stock opened at $17.41 on Wednesday. The company has a quick ratio of 0.69, a current ratio of 0.98 and a debt-to-equity ratio of 0.66. The firm has a market capitalization of $33.35 billion, a PE ratio of 23.24 and a beta of 0.60. The firm’s 50-day simple moving average is $17.00 and its 200 day simple moving average is $18.20. Kenvue Inc. has a 52 week low of $14.02 and a 52 week high of $25.17.

Kenvue (NYSE:KVUE) last released its quarterly earnings results on Monday, November 3rd. The company reported $0.28 EPS for the quarter, beating the consensus estimate of $0.27 by $0.01. Kenvue had a net margin of 9.55% and a return on equity of 20.02%. The business had revenue of $3.76 billion for the quarter, compared to analyst estimates of $3.83 billion. During the same period in the prior year, the business earned $0.28 earnings per share. The company’s quarterly revenue was down 3.5% on a year-over-year basis. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. On average, equities research analysts predict that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, November 26th. Investors of record on Wednesday, November 12th were given a dividend of $0.2075 per share. The ex-dividend date was Wednesday, November 12th. This represents a $0.83 annualized dividend and a yield of 4.8%. Kenvue’s dividend payout ratio is 110.67%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.